Dr Christensen arrived in Cape Town in June 1940 as ship's surgeon on a Danish cargo-liner. Denmark was under German control, and the ship came under command of the South African government for use in war operations. In October 1941, Christensen left the ship to become assistant to Dr Edmond Grasset of the South African Institute for Medical Research in Johannesburg. Later, Christensen was head of department and associate director. Grasset produced the Institute's first concentrated Bitis arietans-Naja nivea antivenom in 1932. When Grasset resigned in 1946, Christensen took over the venom research projects. He introduced changes and produced antisera of high quality. As the paraspecificity of the polyvalent antivenom was limited, Christensen increased the number of immunising antigens to allow treatment against the bite of the many species of viperid and elapid snakes in southern and equatorial Africa. Using pepsin-refined antiserum, Christensen isolated three toxic fractions from Naja nivea venom and showed how the presence of multiple toxins affected antivenom neutralisation curves and estimates of antivenom potency. A member of a WHO Expert Committee, he raised and tested for suitability, the first reference antivenom. Dr Christensen was acclaimed internationally for his expertise, and for his dedicated service to the treatment of snakebite.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0041-0101(00)00216-6DOI Listing

Publication Analysis

Top Keywords

south african
12
christensen
8
african institute
8
institute medical
8
antivenom
6
poul agerholm
4
agerholm christensen
4
christensen 1912-1991
4
1912-1991 antivenom
4
antivenom production
4

Similar Publications

HIV-prevention efforts focusing on women of child-bearing potential are needed to end the HIV epidemic in the African region. The use of antiretroviral drugs as pre-exposure prophylaxis (PrEP) is a critical HIV prevention tool. However, safety data on new antiretrovirals during pregnancy are often limited because pregnant people are excluded from drug development studies.

View Article and Find Full Text PDF

Mpox, formerly referred to as monkeypox, is a viral disease endemic to central Africa, resulting from the monkeypox virus (MPXV). This study provides a current overview of the Mpox epidemic as of 2024, emphasizing significant developments and epidemiological trends. The World Health Organization (WHO) initially designated a clade Ⅱb outbreak as a global health emergency in May 2022, which was subsequently managed through vaccination and public health interventions by May 2023.

View Article and Find Full Text PDF

Killer whales () have been documented to prey on white sharks (), in some cases causing localised shark displacement and triggering ecological cascades. Notably, a series of such predation events have been reported from South Africa over the last decade, with killer whales specifically targeting sharks' liver. However, observations of these interactions are rare, and knowledge of their frequency across the world's oceans remains limited.

View Article and Find Full Text PDF

Introduction: African swine fever is a highly transmissible and lethal infectious disease caused by the African swine fever virus (ASFV), which has considerably impacted the global swine industry. Lipid metabolism plays a vital role in sustaining lipid and energy homeostasis within cells and influences the viral life cycle.

Methods And Results: In this study, we found that ASFV infection disrupts lipid metabolism in the host.

View Article and Find Full Text PDF

Background: Research on the contextual drivers of antimicrobial stewardship (AMS) programme interventions in neonatal units is limited.

Methods: As part of a prospective mixed-methods multidisciplinary neonatal AMS (NeoAMS) interventional study in 14 South African hospitals, we applied a three-phased process to assess implementation barriers and contextual drivers experienced by participating health professionals. The study included: (Phase one; P1) a survey of pre-intervention barriers and enablers; (P2) written feedback during the study intervention phase; and (P3) semi-structured exit interviews.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!